Prevention of group A streptococcal disease in the developing world: investigating innovative control strategies for rheumatic heart disease and impetigo

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1014431

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Group A streptococcal diseases, including rheumatic heart disease and impetigo, are major causes of illness globally, mostly in developing countries. This proposal is a comprehensive investigation into new ways of curbing these diseases, including using ultrasound screening for rheumatic heart disease, community wide treatment for impetigo and laboratory testing for new vaccines. The studies will be done in Fiji and will be relevant for other developing countries and for Indigenous Australians.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2012

Funding Scheme: Early Career Fellowships

Funding Amount: $178,614.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pacific Peoples Health

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Streptococcus pyogenes | impetigo | rheumatic heart disease | scabies | vaccine development

Related Links